Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
-- Here are the latest clinical trials, courtesy of CenterWatch:
Neuropathy
If you have a diagnosis of orthostatic hypotension associated with: Parkinson's disease, multiple system atrophy, pure autonomic failure, dopamine beta hydroxylase...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Experts Worried Over Rising HIV Rates Among U.S. Hispanics
Increasing rates of HIV/AIDS among Hispanics in the United States point to a simmering...
-- Pesticides can help keep your home free of insects, rodents and other unwanted visitors, but exposure to these products can pose serious health risks.
The National Safety Council offers these suggestions when working with pesticides:
Only use...
THURSDAY, July 24 -- When the elderly woman first arrived at Brooke Grove Retirement Village in Sandy Spring, Md., some of the staffers were skeptical when they saw she had brought her cat along.
The woman, in the early stages of dementia, "floated...
-- If you don't carefully monitor your diet, here are a few warning signs that you should, courtesy of the American Academy of Family Physicians:
If your doctor has warned you about health problems or risk factors that can be controlled or improved...
More...
PRINCETON, N.J., July 24, 2008 - Pharmacopeia (NASDAQ: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has identified a new lead for advancement in its alliance with...
NEW YORK--(BUSINESS WIRE)--Jul 24, 2008 - Bristol-Myers Squibb Company (NYSE:BMY) today reported very strong sales and earnings growth for the second quarter 2008 and announced additional plans to proactively manage costs.
"We are making measurable...
Company reports double-digit sales and earnings growth
INDIANAPOLIS, July 24, 2008 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced financial results for the second quarter of 2008.
Second-quarter results are presented on a reported...
HUENENBERG, Switzerland--(BUSINESS WIRE)--Jul 23, 2008 - Alcon, Inc. (NYSE:ACL) reported global sales of $1,735.2 million for the second quarter of 2008, an increase of 17.9 percent compared to the second quarter of 2007, or 11.2 percent excluding...
Despite stagnant erythropoietin (EPO) sales, four new EPO products were introduced in Europe during the last year, but the pipeline shifts from biosimilar based approaches to next generation erythropoiesis stimulating agents (ESA)
BARCELONA, Spain,...
More...
ALAMEDA, Calif.--(BUSINESS WIRE)--Jul 18, 2008 - Celera today announced that it has received marketing
clearance from the U.S. Food and Drug Administration for its 510(k)
submission of the ViroSeq HIV-1 Genotyping System Software v2.8.
The...
COLUMBUS, Ohio, July 14, 2008 /PRNewswire/ -- Roxane
Laboratories, Inc. announced today the approval of its New Drug
Application (NDA) for Morphine Sulfate Tablets and Oral Solution
CII by the U.S. Food and Drug Administration. Roxane...
CARLSBAD, Calif.--(BUSINESS WIRE)--Jul 8, 2008 - Invitrogen
Corporation, a provider of essential life science
technologies for research, production and diagnostics, today
announced it has received U.S. Food and Drug Administration...
First Organ-specific MRI Contrast Agent Approved in the United
States in More Than a Decade
WAYNE, N.J., July 08, 2008 /PRNewswire/ -- Bayer HealthCare
Pharmaceuticals Inc., a leader in diagnostic imaging, announced
today that the U.S. Food and...
LIBERTY CORNER, N.J., July 03, 2008 /PRNewswire/ -- On June 27,
2008 GeneraMedix Inc. received approval from the U.S. Food and Drug
Administration (FDA) for its Epoprostenol for Injection 1.5 mg New
Drug Application (NDA).
Epoprostenol for...
More...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--July 23, 2008--Bristol-Myers Squibb Company and AstraZeneca today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) on June 30th and validation of a...
EAST WINDSOR, N.J.--(BUSINESS WIRE)--July 22, 2008 - NexMed, Inc. today announced the receipt of a non approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for its topical treatment for...
NEWPORT, Ky.--(BUSINESS WIRE)--Jul 22, 2008 - Xanodyne Pharmaceuticals, Inc. announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Zipsor, its candidate for the treatment of patients with mild...
ATLANTA--(BUSINESS WIRE)--Jul 16, 2008 - Sciele Pharma, Inc. today announced that the U.S. Food & Drug
Administration (FDA) has issued an approvable letter for the head
lice treatment. Sciele Pharma is working closely with Summers
Laboratories...
THOUSAND OAKS, Calif., July 14, 2008 — Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment for a rare type of...
More...
SAN DIEGO--(BUSINESS WIRE)--Jul 24, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled,...
MEXICO CITY, July 24, 2008 /PRNewswire/ -- New research from the Journal of the American Medical Association (JAMA) theme issue on HIV/AIDS will be released to the media, coinciding with the International AIDS Conference. Four of the world's top...
CAMBRIDGE, July 24, 2008: Alizyme plc (LSE: AZM) (“Alizyme”) today announces headline results of its European Phase III clinical trial of Colal-Pred in patients with moderate to severe ulcerative colitis.
Highlights
• Results...
WASHINGTON, DC (Tuesday, July 22, 2008) — For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of...
NEW YORK, July 24, 2008 /PRNewswire-FirstCall/ -- MacroChem Corporation today announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical...
More...